New York, New York (PRWEB) January 13, 2013
A total of 176 Pradaxa lawsuits have been filed in the federal multidistrict litigation in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to the Madison Record, U.S. District Judge David Herndon, who is overseeing the federal Pradaxa litigation, recently reported that discovery is well underway. The next Status Conference in the Pradaxa litigation is scheduled for Monday, January 14th. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)*
“We continue to hear from Pradaxa patients who experienced frightening episodes of bleeding while using this blood thinner. We look forward to progress in this litigation in the coming year,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding.
Pradaxa, which is used to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation, was approved by the U.S. Food & Drug Administration (FDA) in October 2010. According to a recent article from Bloomberg.com, internal bleeding is a potential Pradaxa side effect for which there is no readily available antidote. Among other things, Bloomberg stated that the FDA had received reports of 542 deaths and 3,781 side-effect incidents tied to the drug in 2011.**
According to Bloomberg, regulators in several countries have issued Pradaxa safety alerts since the drug was first brought to market. Most recently, the FDA issued a Drug Safety Communication announcing a new contraindication was being added to the Pradaxa label to warn against its use in patients with mechanical heart valves. The FDA acted after participants in a study who were treated with the blood thinner experienced more strokes, heart attacks, and blood clots forming on the mechanical heart valves compared to users of warfarin. There was also more Pradaxa bleeding reported after valve surgery compared to warfarin bleeding, the agency said in the December 19th alert.***
All of the complaints pending in the Southern District of Illinois allege plaintiffs suffered serious, life-threatening episodes of Pradaxa bleeding, and that Boehringer Ingelheim sold the blood thinner despite knowing it could cause fatal bleeding in some patients. According to court documents, Judge Herndon has scheduled the Pradaxa litigation’s first trial for August 2014.
Victims of serious Pradaxa bleeding may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. To learn more please visit the firm’s Pradaxa lawsuit website, or call 1-877-779-1414 to speak with an attorney today.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
Read the full story at http://www.prweb.com/releases/pradaxa-lawsuits/pradaxa-bleeding/prweb10316536.htm.
Copyright©2012 Vocus, Inc.
All rights reserved